XT
ANIK icon

XTX Topco’s Anika Therapeutics ANIK Stock Holding History

XTX Topco’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Sell
17,874
-21,722
-55% -$322K ﹤0.01% 3046
2026
Q1 		$574K Buy
39,596
+17,344
+78% +$201K 0.01% 1911
2025
Q4 		$214K Buy
22,252
+9,482
+74% +$90.8K 0.01% 2352
2025
Q3 		$120K Buy
+12,770
New +$122K 0.01% 1984
2025
Q1 		– Sell
-21,367
Closed -$352K – 2373
2024
Q4 		$352K Buy
+21,367
New +$421K 0.03% 1081
2023
Q4 		– Sell
-28,033
Closed -$522K – 1558
2023
Q3 		$522K Buy
+28,033
New +$581K 0.09% 379

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

XTX Topco's ANIK Position: Q2 2026 in Review

XTX Topco reduced its Anika Therapeutics (ANIK) stake by 55% in Q2 2026, selling an estimated $322K and leaving 17,874 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

XTX Topco first reported a position in ANIK in Q3 2023 and has held it in 6 quarters since. The position peaked at $574K in Q1 2026. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • XTX Topco held 17,874 shares of Anika Therapeutics worth $261K as of Q2 2026.
  • XTX Topco sold 21,722 Anika Therapeutics shares in Q2 2026, an estimated $322K.
  • Anika Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3046 holding.
  • XTX Topco first reported a position in Anika Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • XTX Topco's Anika Therapeutics position peaked at $574K in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.